126 related articles for article (PubMed ID: 2158803)
1. [Ataxia telangiectasia and characterization of its immunological disorders].
Matsumoto S; Sakiyama Y; Kajii N; Okano M; Ishizaka A; Ariga T
No To Hattatsu; 1990 Mar; 22(2):103-11. PubMed ID: 2158803
[TBL] [Abstract][Full Text] [Related]
2. [Ataxia telangiectasia syndrome: clinical picture and immunological abnormalities].
Pietrucha B; Kmieć T; Mikołuć B; Bernatowska E; Jastrzebska-Piotrowska J; Pac M; Wolska-Kuśnierz B; Kuczyński D
Neurol Neurochir Pol; 2004; 38(1 Suppl 1):S1-7. PubMed ID: 15045861
[TBL] [Abstract][Full Text] [Related]
3. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia].
Okano M
Hokkaido Igaku Zasshi; 1986 Jul; 61(4):584-92. PubMed ID: 3019855
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin production in Epstein-Barr virus-transformed lymphoblastoid cell lines in patients with ataxia telangiectasia.
Ariga T; Sakiyama Y; Matsumoto S; Okano M; Osato T
Int Arch Allergy Appl Immunol; 1985; 78(1):33-6. PubMed ID: 2993170
[TBL] [Abstract][Full Text] [Related]
5. Localization of an ataxia-telangiectasia gene to chromosome 11q22-23.
Gatti RA; Berkel I; Boder E; Braedt G; Charmley P; Concannon P; Ersoy F; Foroud T; Jaspers NG; Lange K
Nature; 1988 Dec; 336(6199):577-80. PubMed ID: 3200306
[TBL] [Abstract][Full Text] [Related]
6. Ataxia-telangiectasia or Louis-Bar syndrome.
Smith LL; Conerly SL
J Am Acad Dermatol; 1985 Apr; 12(4):681-96. PubMed ID: 2580869
[TBL] [Abstract][Full Text] [Related]
7. Ataxia-telangiectasia patients presenting with hyper-IgM syndrome.
Noordzij JG; Wulffraat NM; Haraldsson A; Meyts I; van't Veer LJ; Hogervorst FB; Warris A; Weemaes CM
Arch Dis Child; 2009 Jun; 94(6):448-9. PubMed ID: 19224889
[TBL] [Abstract][Full Text] [Related]
8. Ataxia telangiectasia: a review.
Rothblum-Oviatt C; Wright J; Lefton-Greif MA; McGrath-Morrow SA; Crawford TO; Lederman HM
Orphanet J Rare Dis; 2016 Nov; 11(1):159. PubMed ID: 27884168
[TBL] [Abstract][Full Text] [Related]
9. The cytogenetics of ataxia telangiectasia.
Kojis TL; Gatti RA; Sparkes RS
Cancer Genet Cytogenet; 1991 Oct; 56(2):143-56. PubMed ID: 1756458
[TBL] [Abstract][Full Text] [Related]
10. Variants of Nijmegen breakage syndrome and ataxia telangiectasia.
Weemaes CM; Smeets DF; Horstink M; Haraldsson A; Bakkeren JA
Immunodeficiency; 1993; 4(1-4):109-11. PubMed ID: 7513225
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
Joncas JH; Wills A; Reece E; Fox Z
Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
[TBL] [Abstract][Full Text] [Related]
12. Ataxia-telangiectasia presenting with a novel immunodeficiency.
Perreault S; Bernard G; Lortie A; Le Deist F; Decaluwe H
Pediatr Neurol; 2012 May; 46(5):322-4. PubMed ID: 22520355
[TBL] [Abstract][Full Text] [Related]
13. Decreased cytoplasmic immunoglobulin A production during Epstein-Barr virus immortalization on lymphocytes from patients with ataxia-telangiectasia.
Okano M; Sakiyama Y; Matsumoto S; Mizuno F; Osato T
J Clin Lab Anal; 1995; 9(1):77-9. PubMed ID: 7722778
[TBL] [Abstract][Full Text] [Related]
14. Atypical clinical presentation of ataxia telangiectasia.
Willems PJ; Van Roy BC; Kleijer WJ; Van der Kraan M; Martin JJ
Am J Med Genet; 1993 Mar; 45(6):777-82. PubMed ID: 8456862
[TBL] [Abstract][Full Text] [Related]
15. The wasted mutant mouse. II. Immunological abnormalities in a mouse described as a model of ataxia-telangiectasia.
Kaiserlian D; Savino W; Uriel J; Hassid J; Dardenne M; Bach JF
Clin Exp Immunol; 1986 Mar; 63(3):562-9. PubMed ID: 2423278
[TBL] [Abstract][Full Text] [Related]
16. Defective activation of the alternative pathway of complement in two brothers with ataxia-telangiectasia.
Saint-Remy JM; Dent RG; Cole P
J Clin Lab Immunol; 1981 Nov; 6(3):221-6. PubMed ID: 7338883
[TBL] [Abstract][Full Text] [Related]
17. Ataxia-telangiectasia: an interdisciplinary approach to pathogenesis.
Gatti RA; Boder E; Vinters HV; Sparkes RS; Norman A; Lange K
Medicine (Baltimore); 1991 Mar; 70(2):99-117. PubMed ID: 2005780
[TBL] [Abstract][Full Text] [Related]
18. Do elevated serum IgM levels have to be included in probable diagnosis criteria of patients with ataxia-telangiectasia?
Azarsiz E; Karaca NE; Gunaydin NC; Gulez N; Ozturk C; Aksu G; Genel F; Kutukculer N
Int J Immunopathol Pharmacol; 2014; 27(3):421-7. PubMed ID: 25280033
[TBL] [Abstract][Full Text] [Related]
19. Defective anti-polysaccharide antibody response in patients with ataxia-telangiectasia.
Sanal O; Ozbaş-Gerçeker F; Yel L; Ersoy F; Tezcan I; Berkel AI; Metin A; Gatti RA
Turk J Pediatr; 2004; 46(3):208-13. PubMed ID: 15503472
[TBL] [Abstract][Full Text] [Related]
20. [Clinical, biological and genetic study of 24 patients with ataxia telangiectasia from southern Tunisia].
Triki C; Feki I; Meziou M; Turki H; Zahaf A; Mhiri C
Rev Neurol (Paris); 2000 Jul; 156(6-7):634-7. PubMed ID: 10891797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
